Our CEO, Jason Monteleone, took time with PharmaVOICE at this year’s DIA to discuss our CHALLENGE ACCEPTED approach in facing industry challenges for CROs, the ever-changing regulatory environment and the opportunities in the dynamic changes in technology. Watch now:

Back to News